Erdafitinib Drug Interactions
Currently displaying a list of 242 drugs known to interact with erdafitinib.
- 101 major drug interactions
- 138 moderate drug interactions
- 3 minor drug interactions
Medications known to interact with erdafitinib
Note: Showing generic names only.
- abemaciclib
- adagrasib
- afatinib
- alendronate
- alfentanil
- aliskiren
- alprazolam
- aluminum hydroxide
- ambrisentan
- amlodipine
- amprenavir
- apalutamide
- apixaban
- armodafinil
- artesunate
- astemizole
- atazanavir
- atorvastatin
- cabazitaxel
- calcifediol
- calcipotriene topical
- calcitriol
- calcitriol topical
- calcium acetate
- calcium carbonate
- calcium citrate
- calcium glycerophosphate
- calcium phosphate, tribasic
- carbamazepine
- cenobamate
- ceritinib
- chloroquine
- cholecalciferol
- cisapride
- clarithromycin
- clofarabine
- cobicistat
- cobimetinib
- colchicine
- conivaptan
- copanlisib
- cyclosporine
- dabigatran
- dabrafenib
- daclatasvir
- dalfampridine
- daridorexant
- darolutamide
- daunorubicin
- daunorubicin liposomal
- delafloxacin
- delavirdine
- dexamethasone
- digoxin
- dihydroergotamine
- dihydrotachysterol
- docetaxel
- dofetilide
- doxercalciferol
- doxorubicin
- dronedarone
- edoxaban
- efavirenz
- elacestrant
- eliglustat
- elvitegravir
- empagliflozin
- enzalutamide
- epirubicin
- ergocalciferol
- ergonovine
- ergotamine
- erlotinib
- erythromycin
- eslicarbazepine
- etidronate
- etoposide
- etravirine
- everolimus
- felodipine
- fentanyl
- ferric carboxymaltose
- ferric citrate
- ferric pyrophosphate
- fexofenadine
- fidaxomicin
- fosamprenavir
- fosphenytoin
- ibandronate
- idarubicin
- idelalisib
- imatinib
- indacaterol
- indinavir
- isradipine
- itraconazole
- ivacaftor
- ivosidenib
- ixabepilone
- lanthanum carbonate
- lapatinib
- lemborexant
- levamlodipine
- levoketoconazole
- levomethadyl acetate
- linagliptin
- loperamide
- lorlatinib
- lovastatin
- magaldrate
- magnesium amino acids chelate
- magnesium aspartate
- magnesium carbonate
- magnesium chloride
- magnesium citrate
- magnesium gluconate
- magnesium glycinate
- magnesium hydroxide
- magnesium lactate
- magnesium malate
- magnesium oxide
- magnesium salicylate
- magnesium sulfate
- magnesium taurate
- magnesium threonate
- maraviroc
- mavorixafor
- metformin
- methadone
- methylergonovine
- methysergide maleate
- mibefradil
- midazolam
- mitapivat
- mitotane
- mitoxantrone
- modafinil
- nafcillin
- naldemedine
- naloxegol
- nefazodone
- nelfinavir
- nevirapine
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- nintedanib
- niraparib
- nirogacestat
- nisoldipine
- paclitaxel
- paclitaxel protein-bound
- palovarotene
- pamidronate
- paricalcitol
- pemigatinib
- pexidartinib
- phenobarbital
- phenytoin
- phosphorated carbohydrate solution
- pimozide
- posaconazole
- potassium phosphate
- pralsetinib
- primidone
- prucalopride
- ranolazine
- red yeast rice
- revumenib
- rifabutin
- rifampin
- rifapentine
- rifaximin
- riociguat
- ripretinib
- risedronate
- ritonavir
- rivaroxaban
- romidepsin
- rucaparib
- saquinavir
- selexipag
- selpercatinib
- sevelamer
- sildenafil
- silodosin
- simvastatin
- sirolimus
- sodium glycerophosphate
- sodium phosphate
- sofosbuvir
- sotorasib
- st. john's wort
- steviocalcitriol
- sucroferric oxyhydroxide
- sufentanil
- suvorexant
- suzetrigine
- tacrolimus
- tadalafil
- telaprevir
- telithromycin
- telotristat
- temsirolimus
- tenofovir alafenamide
- tenofovir disoproxil
- terfenadine
- thiotepa
- ticagrelor
- tiludronate
- tipranavir
- tolvaptan
- topotecan
- triazolam
- troleandomycin
Erdafitinib disease interactions
There are 3 disease interactions with erdafitinib which include:
Report options
More about erdafitinib
- erdafitinib consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Cisplatin
Cisplatin systemic is used for anal cancer, bladder cancer, blood cell transplantation, bone marrow ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.